Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tenaya Therapeutics Inc

0.6112
+0.00160.26%
Post-market: 0.63550.0243+3.98%16:47 EDT
Volume:1.56M
Turnover:984.60K
Market Cap:99.42M
PE:-0.53
High:0.6600
Open:0.6400
Low:0.6101
Close:0.6096
Loading ...
Feb 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 31, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Jun 13, 2023

Major Issues Report

Form 8-K - Current report
May 10, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2023

Major Issues Report

8-K - Current report
Mar 21, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Mar 08, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 08, 2023

Major Issues Report

8-K - Current report
Mar 08, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 21, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 07, 2022

Major Issues Report

8-K - Current report